60 acast.com Science For The Real World: Canadian Hematology Today https://catalytichealth.com/ en Catalytic Health Catalytic Health

Hosted on Acast. See acast.com/privacy for more information.

]]>

Hosted on Acast. See acast.com/privacy for more information.

]]> false Catalytic Health dominic@catalytichealth.com 686d1f30bf84bb51483a2e48 canadian-hematology-today https://anchor.fm/s/f804f030/podcast/rss episodic https://assets.pippa.io/shows/686d1f30bf84bb51483a2e48/show-cover.jpg https://catalytichealth.com/ Science For The Real World: Canadian Hematology Today https://feeds.acast.com/public/shows/686d1f30bf84bb51483a2e48 Strategic Sequencing in Relapsed Refractory Multiple Myeloma Strategic Sequencing in Relapsed Refractory Multiple Myeloma Tue, 13 Jan 2026 16:53:37 GMT 23:14 696678910b081bb8b91db67f false https://shows.acast.com/canadian-hematology-today/episodes/science-for-the-real-world-canadian-hematology-today-strateg 696678910b081bb8b91db67f 686d1f30bf84bb51483a2e48 science-for-the-real-world-canadian-hematology-today-strateg full 1 5

Hosted on Acast. See acast.com/privacy for more information.

]]>

Hosted on Acast. See acast.com/privacy for more information.

]]> Prise en charge des patients atteints de LLC doublement exposée et réfractaire. Prise en charge des patients atteints de LLC doublement exposée et réfractaire. Tue, 18 Nov 2025 20:58:51 GMT 16:48 691cde0bd712ac48f47893c7 false https://shows.acast.com/canadian-hematology-today/episodes/prise-en-charge-des-patients-atteints-de-llc-doublement-expo 691cde0bd712ac48f47893c7 686d1f30bf84bb51483a2e48 prise-en-charge-des-patients-atteints-de-llc-doublement-expo full 2 1

Hosted on Acast. See acast.com/privacy for more information.

]]>

Hosted on Acast. See acast.com/privacy for more information.

]]> Addressing the management of patients with double exposed and refractory CLL Addressing the management of patients with double exposed and refractory CLL Tue, 18 Nov 2025 18:42:32 GMT 17:40 691cbe19d712ac48f46eaf00 false https://shows.acast.com/canadian-hematology-today/episodes/management-of-double-exposed-and-refractory-cll-patients 691cbe19d712ac48f46eaf00 686d1f30bf84bb51483a2e48 management-of-double-exposed-and-refractory-cll-patients Sponsored by Eli Lilly full 1 4

Hosted on Acast. See acast.com/privacy for more information.

]]>

Hosted on Acast. See acast.com/privacy for more information.

]]> CAR T-cell Therapy in 2025: Evidence, Safety, and Patient Selection CAR T-cell Therapy in 2025: Evidence, Safety, and Patient Selection Wed, 24 Sep 2025 19:00:53 GMT 24:35 68d43fe507474c67718355ce false https://shows.acast.com/canadian-hematology-today/episodes/car-t-therapy-in-2025-evidence-safety-and-patient-selection 68d43fe507474c67718355ce 686d1f30bf84bb51483a2e48 car-t-therapy-in-2025-evidence-safety-and-patient-selection full 1 3

Hosted on Acast. See acast.com/privacy for more information.

]]>

Hosted on Acast. See acast.com/privacy for more information.

]]> Practical considerations in the management of early rrMM in the Canadian context Practical considerations in the management of early rrMM in the Canadian context Mon, 06 Jan 2025 13:00:00 GMT 32:00 77d2d7e2-6e5e-47da-b805-e0b8b7ee50fa false https://podcasters.spotify.com/pod/show/rebecca5354/episodes/Practical-considerations-in-the-management-of-early-rrMM-in-the-Canadian-context-e2setvu 686d1f38594dfad1a25c0987 686d1f30bf84bb51483a2e48 full 1 2 This podcast features Dr. Christopher Venner and his colleagues from the hematology community, Dr. Sylvia McCulloch, Dr. Arleigh McCurdy, and Dr. Chai Phua discussing the approach to the management of early rrMM in the Canadian context.


This episode of Science for the Real World is part of Canadian Hematology Today, an open-access scientific journal for the hematology community.

Hosted on Acast. See acast.com/privacy for more information.

]]> This podcast features Dr. Christopher Venner and his colleagues from the hematology community, Dr. Sylvia McCulloch, Dr. Arleigh McCurdy, and Dr. Chai Phua discussing the approach to the management of early rrMM in the Canadian context.


This episode of Science for the Real World is part of Canadian Hematology Today, an open-access scientific journal for the hematology community.

Hosted on Acast. See acast.com/privacy for more information.

]]> The role of selinexor in early rrMM and sequencing in 2024. The role of selinexor in early rrMM and sequencing in 2024. Wed, 26 Jun 2024 13:39:27 GMT 27:34 e9352eb6-4292-4a71-8297-f2531b76722a false https://podcasters.spotify.com/pod/show/rebecca5354/episodes/The-role-of-selinexor-in-early-rrMM-and-sequencing-in-2024-e2l9mcf 686d1f388d2a216e127c3280 686d1f30bf84bb51483a2e48 full 1 1 In this episode of "Science for the Real World: Canadian Hematology Today," Dr. Peter Anglin hosts a discussion with Dr. Joshua Richter and Dr. Darrell White on the management of early rrMM in 2024, focusing on the role of selinexor and treatment sequencing.


Hosted on Acast. See acast.com/privacy for more information.

]]> In this episode of "Science for the Real World: Canadian Hematology Today," Dr. Peter Anglin hosts a discussion with Dr. Joshua Richter and Dr. Darrell White on the management of early rrMM in 2024, focusing on the role of selinexor and treatment sequencing.


Hosted on Acast. See acast.com/privacy for more information.

]]>